These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36999414)

  • 1. MiRNAs Overexpression and Their Role in Breast Cancer: Implications for Cancer Therapeutics.
    Lee SH; Ng CX; Wong SR; Chong PP
    Curr Drug Targets; 2023; 24(6):484-508. PubMed ID: 36999414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides.
    Geekiyanage H; Rayatpisheh S; Wohlschlegel JA; Brown R; Ambros V
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24213-24223. PubMed ID: 32929008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNA in forming breast carcinoma.
    Saikia M; Paul S; Chakraborty S
    Life Sci; 2020 Oct; 259():118256. PubMed ID: 32822719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenesis of mammalian microRNAs by a non-canonical processing pathway.
    Havens MA; Reich AA; Duelli DM; Hastings ML
    Nucleic Acids Res; 2012 May; 40(10):4626-40. PubMed ID: 22270084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.
    Fan M; Krutilina R; Sun J; Sethuraman A; Yang CH; Wu ZH; Yue J; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(38):27480-27493. PubMed ID: 23921383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Trojan-Horse Strategy by
    Kwak G; Kim H; Park J; Kim EH; Jang H; Han G; Wang SY; Yang Y; Chan Kwon I; Kim SH
    ACS Nano; 2021 Jul; 15(7):11369-11384. PubMed ID: 34191497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.
    Shen J; Xia W; Khotskaya YB; Huo L; Nakanishi K; Lim SO; Du Y; Wang Y; Chang WC; Chen CH; Hsu JL; Wu Y; Lam YC; James BP; Liu X; Liu CG; Patel DJ; Hung MC
    Nature; 2013 May; 497(7449):383-7. PubMed ID: 23636329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention.
    Sengupta D; Deb M; Kar S; Pradhan N; Parbin S; Kirtana R; Singh SP; Suma SG; Niharika ; Roy A; Manna S; Saha P; Chakraborty P; Dash S; Kausar C; Patra SK
    Semin Cancer Biol; 2021 Jul; 72():46-64. PubMed ID: 32497683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
    Wu S; Yu W; Qu X; Wang R; Xu J; Zhang Q; Xu J; Li J; Chen L
    J Hematol Oncol; 2014 May; 7():40. PubMed ID: 24886719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of metastamiR-10b in breast cancer therapeutics.
    Raval A; Joshi J; Shah F
    J Egypt Natl Canc Inst; 2022 May; 34(1):19. PubMed ID: 35491408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review on oncogenic miRNAs in breast cancer.
    Maryam M; Naemi M; Hasani SS
    J Genet; 2021; 100():. PubMed ID: 33764337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.